Literature DB >> 30137260

Frequency of Positive Enzyme Immunoassay for Toxin in Stool of Asymptomatic Carriers of Clostridium difficile.

Yilen K Ng Wong1, Melany Gonzalez-Orta1,2, Carlos Saldana1,2, Jennifer L Cadnum1, Annette L Jencson1, Curtis J Donskey3,4.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30137260     DOI： 10.1093/cid/ciy701

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  6 in total

1.  Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.

Authors:  Alice Y Guh; Kelly M Hatfield; Lisa G Winston; Brittany Martin; Helen Johnston; Geoffrey Brousseau; Monica M Farley; Lucy Wilson; Rebecca Perlmutter; Erin C Phipps; Ghinwa K Dumyati; Deborah Nelson; Trupti Hatwar; Marion A Kainer; Ashley L Paulick; Maria Karlsson; Dale N Gerding; L Clifford McDonald
Journal:  Clin Infect Dis       Date:  2019-10-30       Impact factor: 9.079

2.  Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.

Authors:  Johanna Sandlund; Joel Estis; Phoebe Katzenbach; Niamh Nolan; Kirstie Hinson; Jennifer Herres; Troy Pero; Gwyn Peterson; Jeung-Mi Schumaker; Craig Stevig; Rhonda Warren; Tsubasa West; Siu-Kei Chow
Journal:  J Clin Microbiol       Date:  2019-10-23       Impact factor: 5.948

Review 3.  Ultrasensitive Clostridioides difficile Toxin Testing for Higher Diagnostic Accuracy.

Authors:  Johanna Sandlund; Kerrie Davies; Mark H Wilcox
Journal:  J Clin Microbiol       Date:  2020-05-26       Impact factor: 5.948

4.  Impact of the BioFire FilmArray gastrointestinal panel on patient care and infection control.

Authors:  Julian D Machiels; Amelieke J H Cremers; Muriël C G T van Bergen-Verkuyten; Sandra J M Paardekoper-Strijbosch; Kelly C J Frijns; Heiman F L Wertheim; Janette Rahamat-Langendoen; Willem J G Melchers
Journal:  PLoS One       Date:  2020-02-06       Impact factor: 3.240

5.  Clostridioides difficile toxin is infrequently detected in inflammatory bowel disease and does not associate with clinical outcomes.

Authors:  Rachel Bernard; Muhammad B Hammami; Forest W Arnold; Brian Mcgrath; Alieysa Patel; Brandon Wuerth; Maribeth R Nicholson; Krishna Rao; Dejan Micic
Journal:  Gut Pathog       Date:  2022-08-30       Impact factor: 5.324

6.  Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.

Authors:  Jacob M Parnell; Irtiqa Fazili; Sarah C Bloch; D Borden Lacy; Valeria A Garcia-Lopez; Rachel Bernard; Eric P Skaar; Kathryn M Edwards; Maribeth R Nicholson
Journal:  J Pediatr Gastroenterol Nutr       Date:  2021-03-01       Impact factor: 3.288
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.